Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
798.00    21.00 (2.70%)
Bid:
795.50
Ask:
797.00
Spread: 1.50 (0.189%)
Market Cap: £1.61b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Secondary Placing

5 Mar 2012 07:00

RNS Number : 6614Y
Dunelm Group plc
05 March 2012
 



Dunelm Group plc

5 March 2012

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN

PROPOSED SECONDARY PLACING OF ORDINARY SHARES IN DUNELM GROUP PLC ("DUNELM" OR "THE COMPANY")

Dunelm announces that it has been advised by Will Adderley, Executive Deputy Chairman of the Company, and his wife, Nadine Adderley, that they intend to sell approximately 5 million ordinary shares in the Company in aggregate via an accelerated bookbuild secondary placing (the "Placing"). This represents in aggregate approximately 2.5 per cent of the issued share capital of Dunelm.

The Company has been advised that this proposed sale is aimed at achieving greater portfolio diversification on the part of Will and Nadine Adderley.

 

Assuming that the above number of shares were sold, Will Adderley would continue to have an interest in 65.5 million shares in the Company, representing 32.4 per cent of the issued share capital. The Adderley family as a whole would retain a combined interest in 113.6 million shares in the Company, representing 56.2 per cent of the issued share capital.

 

Will Adderley remains fully committed to Dunelm in his role as Executive Deputy Chairman as well as a very substantial shareholder in the Company.

 

The Placing will be managed by UBS, acting as Bookrunner, and Oriel Securities, acting as Co-Lead Manager. The amount of the Placing proceeds, the number of ordinary shares in the Placing ("Placing Shares") and the placing price will be decided at the close of the accelerated bookbuilding period.

Under the terms of the placing agreement, Will and Nadine Adderley have agreed that, following completion of the Placing, they will not dispose of further shares in the Company for a period of at least six months.

The books for the Placing will open with immediate effect. Pricing and allocations are expected to be announced as soon as practicable following the closing of the books. The timing of closing of the books will be at the absolute discretion of UBS.

 

Enquiries:

UBS +44 (0)20 7567 8000

Craig Calvert

Christopher Smith

Oriel Securities +44 (0)20 7710 7600

Nicholas How

David Arch

 

MHP Communications +44 (0) 20 3128 8100

John Olsen

Simon Hockridge

 

Each of UBS Limited and Oriel Securities is acting on the Placing and will not be responsible to anyone other than its client for providing the protections afforded to its clients, nor for providing advice in relation to the Placing, the contents of this announcement, or any transaction or arrangement referred to herein.

This announcement is for information purposes only and does not constitute or form part of an offer or invitation to acquire or dispose of any securities of Dunelm, or constitute a solicitation of any offer to purchase or subscribe for securities in any jurisdiction, including the United States, Canada, Australia or Japan. Dunelm's shares have not been, and will not be, registered under the United States Securities Act of 1933, as amended, or under the securities legislation of any state of the United States and may not be offered or sold in the United States absent registration or an exemption from registration.

Dunelm's shares may not, directly or indirectly, be offered or sold within the United States, Canada, Australia or Japan or offered or sold to a resident of Canada, Australia or Japan. No public offering of securities is being made in the United States.

This announcement is not for publication or distribution to persons in the United States of America, its territories or possessions or to any US person (within the meaning of Regulation S under the US Securities Act of 1933, as amended). Neither this announcement nor any copy of it may be taken or transmitted into Australia, Canada or Japan or to Canadian persons or to any securities analyst or other person in any of those jurisdictions. Any failure to comply with this restriction may constitute a violation of United States, Australian, Canadian or Japanese securities law. The distribution of this announcement in certain other jurisdictions may be restricted by law and persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

This announcement and any offer of securities to which it relates are only addressed to and directed at persons who are (1) qualified investors within the meaning of directive 2003/71/ec and any relevant implementing measures (the prospectus directive) and (2) who have professional experience in matters relating to investments who fall within article 19(1) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order") or are persons falling within article 49(2)(a) to (d) ("High Net Worth Companies, Unincorporated Associations, etc") of the Order (all such persons together being referred to as "relevant persons"). The information regarding the Placing set out in this announcement must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this announcement relates is available only to relevant persons and will be engaged in only with relevant persons.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSWSMIFESELD
Date   Source Headline
19th Nov 20192:25 pmRNSResult of AGM
15th Nov 20193:10 pmRNSHolding(s) in Company
14th Nov 20197:00 amRNSSharesave option granted to Laura Carr
31st Oct 20197:00 amRNSTotal Voting Rights
22nd Oct 20197:00 amRNSBlock listing Interim Review
22nd Oct 20197:00 amRNSBlock listing Interim Review
22nd Oct 20197:00 amRNSBlock listing Interim Review
22nd Oct 20197:00 amRNSBlock listing Interim Review
17th Oct 20199:45 amRNSHolding(s) in Company
17th Oct 20197:00 amRNSDirector/PDMR Shareholding
15th Oct 20195:20 pmRNSHolding(s) in Company
10th Oct 20197:00 amRNSFirst Quarter Trading Update
9th Oct 20197:00 amRNSAnnual Financial Report
27th Sep 20197:00 amRNSTotal Voting Rights
6th Sep 20197:00 amRNSDirector/PDMR Shareholding
4th Sep 20197:00 amRNSDirectorate Change
4th Sep 20197:00 amRNSFinal Results
30th Aug 20197:00 amRNSTotal Voting Rights
1st Aug 20197:00 amRNSTotal Voting Rights
18th Jul 20197:00 amRNSDirector/PDMR Shareholding
12th Jul 20197:00 amRNSDirector/PDMR Shareholding
10th Jul 20197:00 amRNSDirectorate Change
10th Jul 20197:00 amRNSFourth Quarter Trading Update
28th Jun 20197:00 amRNSTotal Voting Rights
20th Jun 20197:00 amRNSTrading Update
31st May 20197:00 amRNSTotal Voting Rights
10th Apr 20197:00 amRNSThird Quarter Trading Update
9th Apr 20197:00 amRNSBlock listing Interim Review
9th Apr 20197:00 amRNSBlock listing Interim Review
9th Apr 20197:00 amRNSBlock listing Interim Review
9th Apr 20197:00 amRNSBlock listing Interim Review
29th Mar 20197:00 amRNSTotal Voting Rights
13th Feb 20197:00 amRNSInterim Results
7th Jan 20197:00 amRNSSecond Quarter Trading Update
7th Dec 20187:00 amRNSGift of shares and Director/PDMR holding
7th Dec 20187:00 amRNSHolding(s) in Company
7th Dec 20187:00 amRNSHolding(s) in Company
7th Dec 20187:00 amRNSHolding(s) in Company
3rd Dec 20187:01 amRNSDirector/PDMR Shareholding
3rd Dec 20187:00 amRNSDirector/PDMR Shareholding
29th Nov 201812:40 pmRNSResult of AGM
29th Nov 20187:00 amRNSConfirmation of Board Changes
16th Nov 20188:14 amRNSSharesave option granted to Nick Wilkinson
30th Oct 20187:00 amRNSTotal Voting Rights
18th Oct 20187:00 amRNSDirector/PDMR Shareholding
15th Oct 20187:00 amRNSDirector/PDMR Shareholding
11th Oct 20187:00 amRNSFirst Quarter Trading Update
9th Oct 20187:00 amRNSAnnual Financial Report
5th Oct 20187:00 amRNSBlock listing Interim Review
5th Oct 20187:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.